SCS Capital Management LLC Buys 2,961 Shares of UnitedHealth Group Incorporated $UNH

SCS Capital Management LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 64.2% during the 2nd quarter, HoldingsChannel reports. The firm owned 7,570 shares of the healthcare conglomerate’s stock after buying an additional 2,961 shares during the period. SCS Capital Management LLC’s holdings in UnitedHealth Group were worth $2,362,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Brighton Jones LLC lifted its position in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its holdings in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the period. Ted Buchan & Co increased its holdings in shares of UnitedHealth Group by 4.0% in the 1st quarter. Ted Buchan & Co now owns 5,900 shares of the healthcare conglomerate’s stock valued at $3,090,000 after acquiring an additional 229 shares during the period. Chicago Partners Investment Group LLC lifted its stake in shares of UnitedHealth Group by 8.3% during the 1st quarter. Chicago Partners Investment Group LLC now owns 3,644 shares of the healthcare conglomerate’s stock worth $1,909,000 after purchasing an additional 280 shares during the last quarter. Finally, AlphaCore Capital LLC raised its holdings in UnitedHealth Group by 652.2% in the first quarter. AlphaCore Capital LLC now owns 4,867 shares of the healthcare conglomerate’s stock worth $2,549,000 after purchasing an additional 4,220 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.9%

Shares of NYSE:UNH opened at $330.61 on Friday. The business has a 50-day moving average price of $341.79 and a 200-day moving average price of $315.93. The stock has a market cap of $299.48 billion, a price-to-earnings ratio of 17.26, a PEG ratio of 2.18 and a beta of 0.43. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.15 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on UNH. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective for the company. in a research report on Wednesday, October 29th. TD Cowen increased their price target on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday, October 30th. Finally, Bank of America upped their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. Seventeen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $385.54.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.